SLG
NITE

Stanley-Laman Group’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Stanley-Laman Group’s Portfolio NITE Stock Details NITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-12,181
Closed -$195K – 240
2018
Q2 		$195K Buy
+12,181
New +$174K 0.04% 255

Other funds holding NITE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

Stanley-Laman Group's NITE Position: Q3 2018 in Review

Stanley-Laman Group sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q3 2018, closing a stake of 12,181 shares — an estimated $195K sold.

Stanley-Laman Group first reported a position in NITE in Q2 2018 and held it in 1 quarter. The position peaked at $195K in Q2 2018. 36 funds tracked by Wall St. Rank hold NITE as of Q3 2018.

  • Stanley-Laman Group reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q3 2018 after selling out during the quarter.
  • Stanley-Laman Group sold 12,181 Nightstar Therapeutics plc American Depositary Shares shares in Q3 2018, an estimated $195K.
  • Stanley-Laman Group first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q2 2018 and held it in 1 quarter.
  • Stanley-Laman Group's Nightstar Therapeutics plc American Depositary Shares position peaked at $195K in Q2 2018.
  • 36 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q3 2018.

Based on Stanley-Laman Group's 13F filing for Q3 2018, filed 30 Oct 2018.